GC19020
ACY-738
Also known as N-hydroxy-2-[(1-phenylcyclopropyl)amino]pyrimidine-5-carboxamide
ACY-738 is a potent, selective and orally-bioavailable HDAC6 inhibitor, with an IC50s of 1·7 nM; ACY-738 also inhibits HDAC1, HDAC2, and HDAC3, with IC50s of 94, 128, and 218 nM
ChemicalCAS1375465-91-0MW270.29FormulaC14H14N4O2
- CAS number
- 1375465-91-0
- Molecular weight
- 270.29
- Formula
- C14H14N4O2
- Solubility
- DMSO ： ≥ 32 mg/mL (118·39 mM)
- InChIKey
- LIIWIMDSZVNYHY-UHFFFAOYSA-N
- Catalogue number
- GC19020
- Brand
- GLPBIO
Computed properties PubChem CID 57381425 · XLogP 1.1 · TPSA 87.1 Ų · H-bond donors 3
- XLogP
- 1.1
- TPSA
- 87.1 Ų
- H-bond donors
- 3
- H-bond acceptors
- 5
- Rotatable bonds
- 4
- Heavy atoms
- 20
SMILES C1CC1(C2=CC=CC=C2)NC3=NC=C(C=N3)C(=O)NO
Computed descriptors from PubChem (CID 57381425), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il